Ethambutol Hcl (ethambutol HCl)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Ethambutol hydrochloride is a synthetic antituberculosis agent.

USES: Ethambutol is used with other medications to treat tuberculosis (TB). Ethambutol is an antibiotic and works by stopping the growth of bacteria. This antibiotic treats only bacterial infections.

It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Generic name: ethambutol HCl
Pronunciation: (eth-AM-bue-tol)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Ethambutol Hcl

Intelligence content is not available yet.

Indications

The following indications are listed for Ethambutol Hcl:

  • Active Tuberculosis
  • Pulmonary Tuberculosis

Also known as: Active Tb, Acute Tuberculosis, Pulmonary Tb.

Dosing

In patients with impaired renal function, doses and/or frequency of administration of ethambutol hydrochloride should be modified in response to the degree of renal impairment. Some clinicians suggest that if the creatinine clearance is 70-100 mL/minute, dosage of ethambutol hydrochloride should not exceed 15 mg/kg daily, and if the creatinine clearance is less than 70 mL/minute, dosage should be further reduced. Other clinicians have suggested that the usual dose be administered every 24-36 hours in patients with creatinine clearances of 10-50 mL/minute and every 48 hours in patients with creatinine clearances less than 10 mL/minute.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data